首页> 美国卫生研究院文献>other >Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues
【2h】

Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues

机译:复发性三阴性乳腺癌(TNBC)组织比非复发性TNBC组织中磷脂酰胆碱(32:1)的含量更高

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Triple-negative breast cancer (TNBC) is one of the breast cancer subtype that displays a high risk of early recurrence and short overall survival. Improvement of the prognosis of patients with TNBC requires identifying a predictive factor of recurrence, which would make it possible to provide beneficial personalized treatment. However, no clinically reliable predictive factor is currently known. In this study, we investigated the predictive factor of recurrence in TNBC using matrix-assisted laser desorption/ionization-imaging mass spectrometry for lipid profiling of breast cancer specimens obtained from three and six patients with recurrent and non-recurrent TNBC, respectively. The signal for phosphatidylcholine (PC) (32:1) at m/z 732.5 was significantly higher in the recurrence group compared to the non-recurrence group (P = 0.024). PC (32:1) was more abundant in the cancer epithelial area than it was in the surrounding stroma, suggesting that abnormal lipid metabolism was associated with malignant transformation. Our results indicate PC (32:1) as a candidate predictive factor of TNBC recurrence. A future prospective study investigating whether personalized therapy based on PC (32:1) intensity improves the prognosis of patients with TNBC is recommended.
机译:三阴性乳腺癌(TNBC)是显示早期复发高风险和较短总体生存期的乳腺癌亚型之一。 TNBC患者预后的改善需要确定复发的预测因素,这将有可能提供有益的个性化治疗。但是,目前尚无临床可靠的预测因素。在这项研究中,我们使用基质辅助激光解吸/电离成像质谱技术研究了分别从三名和六名患有复发性和非复发性TNBC的患者获得的乳腺癌标本中的脂质谱,研究了TNBC复发的预测因素。与非复发组相比,复发组中磷脂酰胆碱(PC)的信号(32:1)在m / z 732.5处显着更高(P = 0.024)。 PC(32:1)在癌上皮区域比在周围基质中更为丰富,表明脂质代谢异常与恶性转化有关。我们的结果表明PC(32:1)是TNBC复发的候选预测因素。建议进行一项未来的前瞻性研究,以调查基于PC(32:1)强度的个性化治疗是否可以改善TNBC患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号